$80.30
-0.72 (-0.89%)
VIK News5 articles
AI, Retail, and Travel Surge: 5 Stocks to Watch Next Week
Ross Stores and Howmet Aerospace lead a list of five stocks to watch next week, driven by strong earnings and bullish technical setups. Investors await second-quarter results.
Viking Surges 24% as Monthly VK2735 Retains 85% Weight Loss
Viking Therapeutics (VKTX) soared 24% premarket after monthly VK2735 dosing preserved 85% of prior weight loss, signaling strong potential for its obesity pipeline.
Viking Therapeutics Faces Cash Runway Questions Ahead of Q2 Report
Viking Therapeutics shares fell 6.2% last week as analysts increased Q2 loss estimates by 24% to $1.23 per share. The company's cash runway faces scrutiny ahead of earnings on July 29.
Viking Therapeutics Holds Phase 3 Focus Despite Weekly Stock Dip
Viking Therapeutics shares declined 4.6% over the past week, yet its valuation premium over Structure Therapeutics persists, reflecting continued investor confidence in its Phase 3 obesity programs.
Viking Therapeutics Surges on Obesity Drug Hopes
Viking Therapeutics shares climbed 6% to $34.30 as investors bet on upcoming Phase 3 data for its obesity drug VK2735, expected in Q3 2026.